Immunomodulation of functional T cell assays for diagnosis of infectious or autoimmune disorders
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorNiaz Banaei
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorNiaz Banaei
Estimating the term…
Improved assays for detecting the presence of a specific cell-mediated immune response in an individual are provided, where a sample comprising T cells and other cells of the immune system, usually a blood sample or derivative thereof, is contacted with test antigen(s) of interest in the presence of a pattern recognition receptor (PRR) agonist. The sample is incubated for a period of time sufficient to activate effector T cells; and release of immune effector molecule(s) is then detected. In some embodiments, the PRR is an agonist of a toll-like receptor (TLR) expressed by mature antigen presenting cells, including without limitation agonists TLR3 and TLR7, such as LPS, poly I:C, imiquimod, etc.
A method for measuring a cell mediated immune (CMI) response to a tuberculosis antigen in a subject, said method comprising:
Dependencies are inferred from the claim text.